# OnCo record thygenext-thyramir (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/thygenext-thyramir/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "thygenext-thyramir" ;
  schema:name "ThyGeNEXT and ThyraMIR v2"@en ;
  schema:alternateName "ThyGeNEXT"@en, "ThyraMIR"@en, "Interpace multiplatform thyroid test"@en, "ThyGeNEXT / ThyraMIR" ;
  schema:description "A pair of tests on a thyroid nodule needle sample, one reading DNA and RNA fusions and one reading small regulatory RNAs, to judge whether an uncertain nodule is likely to be cancer."@en ;
  schema:url <https://onco.cc/drugs/thygenext-thyramir/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://thygenext-thyramir.com/> ;
  onco:status "established" ;
  onco:tag "test", "rna" ;
  onco:modality "DNA mutation, RNA fusion and microRNA classifier (thyroid nodule aspirates)" ;
  onco:related <https://onco.cc/drugs/thyroseq/>, <https://onco.cc/drugs/afirma/> ;
  onco:cancers <https://onco.cc/cancers/thyroid/> ;
  onco:technologies <https://onco.cc/technologies/thyroid-fna-molecular/> ;
  onco:companies <https://onco.cc/companies/interpace-biosciences/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-lupo-multiplatform-thyroid-nodule-diagn-cytopathol-2020/> .
